We first attempted to detect EGFR homodimers in seven NSCLC cell lines (Supplementary Table 1) positive or negative for activating EGFR mutations with the use of PLA probes derived from a monoclonal antibody to EGFR. Here, EGFR is linked to non-small cell lung carcinoma.